Skip to main content
Enhabit, Inc. (EHAB)
NYSE: EHAB · Real-Time Price · USD
7.65
-0.05 (-0.65%)
Dec 20, 2024, 4:00 PM EST - Market closed

Enhabit Revenue

Enhabit had revenue of $253.60M in the quarter ending September 30, 2024, a decrease of -1.82%. This brings the company's revenue in the last twelve months to $1.04B, down -1.11% year-over-year. In the year 2023, Enhabit had annual revenue of $1.05B, down -2.32%.

Revenue (ttm)
$1.04B
Revenue Growth
-1.11%
P/S Ratio
0.37
Revenue / Employee
$96,037
Employees
10,800
Market Cap
384.67M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.05B-24.80M-2.32%
Dec 31, 20221.07B-35.50M-3.21%
Dec 31, 20211.11B28.40M2.63%
Dec 31, 20201.08B-13.80M-1.26%
Dec 31, 20191.09B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Akebia Therapeutics 169.88M
Arcturus Therapeutics Holdings 160.40M
National Research 144.16M
Y-mAbs Therapeutics 84.55M
Alpha Teknova 36.35M
Nano-X Imaging 10.68M
Allogene Therapeutics 43.00K
Revenue Rankings

EHAB News

More News